Drug Manufacturers - Specialty & Generic · Healthcare
CFO
Equibles does not estimate personal net worth.
Get an email with a short summary when Verano Holdings Corp. publishes a filing, an earnings call transcript or a press release.
Get VRNO alertsRichard Tarapchak is recorded as CFO at Verano Holdings Corp. (VRNO). The newest filing on record that lists Richard Tarapchak as CFO at Verano Holdings Corp. (VRNO) is dated April 29, 2026. Verano Holdings Corp. reported in an 8-K filed April 14, 2025 that Richard Tarapchak was appointed Chief Financial Officer, effective April 11, 2025. The proxy statement of Verano Holdings Corp. reports total compensation of $937,696 for Richard Tarapchak in fiscal 2025, including a base salary of $390,659. Richard Tarapchak has spoken on 3 earnings calls across 1 company, most recently for Verano Holdings Corp. on October 29, 2026. Verano Holdings Corp. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Verano Holdings Corp. includes George Archos (CEO and Board Member), Trip McDermott (COO), Laura Kalesnik (General Counsel) and 7 others.
“On April 11, 2025, Richard Tarapchak was promoted and appointed as the Chief Financial Officer of the Company and its subsidiaries and was designated as the Company’s Principal Financial Officer.”
“The third quarter featured strong organic growth versus the prior year period, highlighted by $212 million in revenue, an increase of $10 million or 5%, and a significant improvement in cash flow from operations.”
“First quarter revenue was $208 million, an increase of $2 million sequentially, and a decrease of $2 million versus the prior year period.”
“Starting with the fourth quarter results, revenue was $207 million, an increase of 2% sequentially, and a decrease of 5% versus the prior year period.”
Start not stated–present
Last confirmed April 29, 2026
Proxy statement
Start not stated–2024-04-29
Last confirmed by a filing; no departure on record
Drug Manufacturers - Specialty & Generic · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Verano Holdings Corp. (VRNO) | – Chief Financial Officer and Treasurer | $390,659 | $937,696 |